Measurement of Cerebral Perfusion Indices from the Early Phase of [18F]MK6240 Dynamic Tau PET Imaging
暂无分享,去创建一个
G. Fakhri | B. Hanseeuw | N. Guehl | M. Normandin | Sung-Hyun Moon | Julie C. Price | K. Johnson | Maeva Dhaynaut | J. Fu | Emma G. Thibault | C. Lois
[1] R. Boellaard,et al. A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F]MK-6240 , 2021, EJNMMI Research.
[2] A. Lammertsma,et al. Test-Retest Variability of Relative Tracer Delivery Rate as Measured by [11C]PiB , 2021, Molecular Imaging and Biology.
[3] W. M. van der Flier,et al. Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[4] Özgür A. Onur,et al. Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[5] S. Resnick,et al. Longitudinal evaluation of surrogates of regional cerebral blood flow computed from dynamic amyloid PET imaging , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] C. Broeckhoven,et al. 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET , 2019, Alzheimer's & Dementia.
[7] Marc D. Normandin,et al. Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [18F]MK6240 in human subjects , 2019, European Journal of Nuclear Medicine and Molecular Imaging.
[8] J. Berkhof,et al. Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies , 2019, EJNMMI Research.
[9] Sterling C. Johnson,et al. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand 18F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls , 2018, The Journal of Nuclear Medicine.
[10] R. Boellaard,et al. Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer’s disease PET studies , 2019, PloS one.
[11] R. Boellaard,et al. Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer’s disease , 2019, EJNMMI Research.
[12] S. Gauthier,et al. In vivo quantification of neurofibrillary tangles with [18F]MK-6240 , 2018, Alzheimer's Research & Therapy.
[13] Talakad G. Lohith,et al. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles , 2018, The Journal of Nuclear Medicine.
[14] C. Jack,et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.
[15] A. Drzezga,et al. Multimodal correlation of dynamic [18F]-AV-1451 perfusion PET and neuronal hypometabolism in [18F]-FDG PET , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[16] N. Okamura,et al. Perfusion-Phase [18F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration , 2017, Journal of Alzheimer's disease reports.
[17] G. Bormans,et al. cGMP production of the radiopharmaceutical [18 F]MK-6240 for PET imaging of human neurofibrillary tangles. , 2017, Journal of labelled compounds & radiopharmaceuticals.
[18] Keith A. Johnson,et al. Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects , 2017, The Journal of Nuclear Medicine.
[19] Anders Wall,et al. Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer’s disease , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] Keith A. Johnson,et al. Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals. , 2016, JAMA neurology.
[21] Talakad G. Lohith,et al. Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles , 2016, The Journal of Nuclear Medicine.
[22] Keith A. Johnson,et al. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers , 2016, Neurology.
[23] Frederik Barkhof,et al. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease , 2016, European Radiology.
[24] Ove Almkvist,et al. Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease , 2016, The Journal of Nuclear Medicine.
[25] Jorge Sepulcre,et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease , 2016, Annals of neurology.
[26] Oscar L Lopez,et al. Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET , 2015, The Journal of Nuclear Medicine.
[27] Maja A. A. Binnewijzend,et al. Cerebral perfusion in the predementia stages of Alzheimer’s disease , 2015, European Radiology.
[28] A. Gjedde,et al. Blood-brain transfer of Pittsburgh compound B in humans , 2013, Front. Aging Neurosci..
[29] Denise C. Park,et al. Alterations in cerebral metabolic rate and blood supply across the adult lifespan. , 2011, Cerebral cortex.
[30] Nick C Fox,et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[31] Keith A. Johnson,et al. Amyloid-β Associated Cortical Thinning in Clinically Normal Elderly , 2011, Annals of neurology.
[32] M. Hüll,et al. Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and 11C-Labeled Pittsburgh Compound B , 2011, The Journal of Nuclear Medicine.
[33] J. Trojanowski,et al. Distinct cerebral perfusion patterns in FTLD and AD , 2010, Neurology.
[34] Gunnar Antoni,et al. Unidirectional Influx and Net Accumulation of PIB , 2008, The open neuroimaging journal.
[35] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[36] Alan A. Wilson,et al. A rapid one-step radiosynthesis of the β-amyloid imaging radiotracer N-methyl-[11C]2-(4′-methylaminophenyl)-6-hydroxybenzothiazole ([11C]-6-OH-BTA-1) , 2004 .
[37] Richard E Carson,et al. Noise Reduction in the Simplified Reference Tissue Model for Neuroreceptor Functional Imaging , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[38] Michael Brady,et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.
[39] A. Dale,et al. Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.
[40] Keith A. Johnson,et al. Perfusion abnormalities in prodromal AD , 2000, Neurobiology of Aging.
[41] J. Démonet,et al. Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[42] D. Berdichevsky,et al. Improved Methods for Image Registration , 1996, NeuroImage.
[43] Richard S. J. Frackowiak,et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. , 1990, Brain : a journal of neurology.
[44] M. Mintun,et al. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[45] M. Raichle,et al. Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[46] Salvatore Mazza,et al. Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. , 2011, Journal of Alzheimer's disease : JAD.
[47] Sterling C. Johnson,et al. Effects of hypoperfusion in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[48] Nikos Makris,et al. Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.